Latest Menorrhagia Stories
PMS is that dreaded term that many women - and men - dread every month. The emotional rollercoaster is thought to affect about eight out of 10 women - however, many younger women don't realise they have it and are being treated for depression and anxiety instead.
SAN DIEGO, Sept. 2 /PRNewswire-FirstCall/ -- Neurocrine Biosciences, Inc.
Repros Therapeutics Inc.
NEWPORT, Ky., Aug. 5 /PRNewswire/ -- Xanodyne Pharmaceuticals, Inc.
Repros Therapeutics Inc. (NasdaqGM:RPRX) today announced that the results of the initial Phase I/II clinical trial of Proellex(R) which was conducted in Europe are to be published in US Obstetrics and Gynecology Review in early August.
ANN ARBOR, Mich., July 17 /PRNewswire/ -- Meditrina Pharmaceuticals, Inc.
Repros Therapeutics Inc. (NasdaqGM:RPRX) today released strong results from its completed extension safety study of Proellex in the chronic treatment of the symptoms associated with uterine fibroids.
WALTHAM, Mass., July 10 /PRNewswire/ -- According to Millennium Research Group's Global Markets for Hysterectomy Alternatives 2008 report, which covers global endometrial ablation (GEA) devices, uterine artery embolization (UAE) devices, hysteroscopes, and endometrial resection devices, the global hysterectomy market will generate more than $700 million in 2012, primarily driven by expanding GEA procedure volumes.
By Anna Tong, The Lexington Herald-Leader, Ky. Jul. 1--A medical malpractice case in which an Owingsville woman accused a Lexington gynecologist of unnecessary castration -- removing her healthy ovaries -- without warning her of the surgery's consequences went to the jury Tuesday.
A new study from researchers at the University of Iowa has found that shortened times between menstrual periods may be an initial sign of menopause, while heavy bleeding seems to have other causes.
- A trick or prank.